Each year, advances in biomedical science save the lives of tens of thousands of children
worldwide, prevent or limit disease or disability in many more, and improve the quality
of life for countless others. Still, pediatricians and others have long argued that
infants, children, and adolescents have not shared equally with adults in biomedical
progress. In particular, many drugs that are prescribed for children have not been
tested with children. This gap puts them at risk for dosing miscalculations and preventable
harms related to metabolic and other differences between children and adults.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Academic PediatricsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Possible barriers to the availability of medical devices intended to treat or diagnose diseases and conditions that affect children; Request for comments.Fed Reg. 2004; 69: 34374-34375
- Field MJ Behrman RE Ethical Conduct of Clinical Research Involving Children. National Academy Press, Washington, DC2004
- Federman DD Hanna KE Rodriguez LL Responsible Research: A Systems Approach to Protecting Research Participants. National Academy Press, Washington, DC2003
- Ethical and Policy Issues in Research Involving Human Participants. National Bioethics Advisory Commission, Bethesda, Md2001
- Assessment of risk in research on children.J Pediatr. 1981; 98: 842-846
- Adolescent Medicine HIV/AIDS Research Network. A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs.Instit Rev Board. 1999; 21: 6-10
- The ethics of pediatric research. Presented to the Committee on Clinical Research Involving Children, Institute of Medicine, Washington, DCJanuary 9, 2003
- How do institutional review boards apply the federal risk and benefit standards for pediatric research?.JAMA. 2004; 291: 476-482
- A History and Theory of Informed Consent. Oxford University Press, New York, NY1986
- The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. US Government Printing Office, Washington, DC1978
Article info
Publication history
Accepted:
October 21,
2004
Received:
September 8,
2004
Identification
DOI: https://doi.org/10.1367/1539-4409(2005)5<47:RRIC>2.0.CO;2
Copyright
© 2005 Ambulatory Pediatric Association. Published by Elsevier Inc. All rights reserved.
